MY8600389A - Topical formulations of 9-(2-hydroxyethoxymethyl) guanine - Google Patents

Topical formulations of 9-(2-hydroxyethoxymethyl) guanine

Info

Publication number
MY8600389A
MY8600389A MY389/86A MY8600389A MY8600389A MY 8600389 A MY8600389 A MY 8600389A MY 389/86 A MY389/86 A MY 389/86A MY 8600389 A MY8600389 A MY 8600389A MY 8600389 A MY8600389 A MY 8600389A
Authority
MY
Malaysia
Prior art keywords
hydroxyethoxymethyl
guanine
topical formulations
topical
formulations
Prior art date
Application number
MY389/86A
Other languages
English (en)
Inventor
Jones
Trevor Mervyn
White Alan Robert
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8600389(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MY8600389A publication Critical patent/MY8600389A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY389/86A 1980-07-18 1986-12-30 Topical formulations of 9-(2-hydroxyethoxymethyl) guanine MY8600389A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (1)

Publication Number Publication Date
MY8600389A true MY8600389A (en) 1986-12-31

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
MY389/86A MY8600389A (en) 1980-07-18 1986-12-30 Topical formulations of 9-(2-hydroxyethoxymethyl) guanine

Country Status (30)

Country Link
EP (1) EP0044543B1 (el)
AR (1) AR225680A1 (el)
AT (1) AT381025B (el)
AU (1) AU547391B2 (el)
BG (1) BG60450B2 (el)
CA (1) CA1172169A (el)
CS (1) CS229674B2 (el)
CY (1) CY1309A (el)
DD (1) DD203464A5 (el)
DE (1) DE3163982D1 (el)
DK (1) DK149191C (el)
ES (1) ES8305363A1 (el)
FI (1) FI76255C (el)
GB (1) GB2080106B (el)
GR (1) GR75104B (el)
HK (1) HK95485A (el)
HU (1) HU185936B (el)
IE (1) IE51120B1 (el)
IL (1) IL63351A (el)
IT (1) IT1171399B (el)
MC (1) MC1408A1 (el)
MY (1) MY8600389A (el)
NO (1) NO155038C (el)
NZ (1) NZ197744A (el)
PH (1) PH16308A (el)
PL (1) PL135416B1 (el)
PT (1) PT73391B (el)
RO (1) RO82678A (el)
SG (1) SG72085G (el)
ZW (1) ZW17181A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
DE69313895T2 (de) * 1992-03-20 1998-02-12 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ATE396732T1 (de) * 2004-04-05 2008-06-15 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
CA1172169A (en) 1984-08-07
ES504046A0 (es) 1983-04-01
PH16308A (en) 1983-09-05
NO812464L (no) 1982-01-19
HK95485A (en) 1985-12-06
GR75104B (el) 1984-07-13
FI812257L (fi) 1982-01-19
CS229674B2 (en) 1984-06-18
MC1408A1 (fr) 1982-07-16
IL63351A0 (en) 1981-10-30
ES8305363A1 (es) 1983-04-01
AT381025B (de) 1986-08-11
HU185936B (en) 1985-04-28
PT73391B (en) 1983-06-15
AU547391B2 (en) 1985-10-17
PL232259A1 (en) 1983-07-04
DE3163982D1 (en) 1984-07-12
SG72085G (en) 1986-05-02
IT8148925A0 (it) 1981-07-17
IE51120B1 (en) 1986-10-01
FI76255C (fi) 1990-03-14
DK149191B (da) 1986-03-10
AU7307381A (en) 1982-01-21
IE811617L (en) 1982-01-18
ATA318081A (de) 1986-01-15
FI76255B (fi) 1988-06-30
ZW17181A1 (en) 1983-02-23
EP0044543A1 (en) 1982-01-27
PT73391A (en) 1981-08-01
NO155038C (no) 1987-02-04
AR225680A1 (es) 1982-04-15
IL63351A (en) 1983-10-31
DK149191C (da) 1986-09-08
GB2080106A (en) 1982-02-03
CY1309A (en) 1985-12-06
IT1171399B (it) 1987-06-10
GB2080106B (en) 1984-03-07
DD203464A5 (de) 1983-10-26
BG60450B2 (bg) 1995-04-28
PL135416B1 (en) 1985-10-31
RO82678A (ro) 1984-05-23
NZ197744A (en) 1983-05-10
DK321681A (da) 1982-01-19
NO155038B (no) 1986-10-27
EP0044543B1 (en) 1984-06-06

Similar Documents

Publication Publication Date Title
DE3163982D1 (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
US4355032B2 (en) 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
HK82292A (en) Guanine compounds and their use for the preparation of antiviral agents
IL70164A0 (en) Compositions containing 8-substituted guanine derivatives and methods of using same
AU1527983A (en) Topical pharmaceutical compositions containing 9- (2-hydroxyethoxymethyl) guanine
HK126093A (en) Antiviral guanine derivatives
PT81160A (en) Process for the preparation of anti-virous compositions from 9-(4-hydroxi-3-hydroximethylbut-1-yl) guanine
JPS5467845A (en) Tool of carrying wheel
ZA786933B (en) Actinic radiation-curable formulations
GB2151622B (en) Novel derivatives of guanine
DE3571985D1 (en) 8-substituted guanine derivatives
GB2097785B (en) Novel purine derivatives
YU219084A (en) Process for preparation of 9-(2-hydroxi-etoxi-methyl) guanine
AU521577B2 (en) 9-hydroxyethoxymethyl guanine phosphates
KE3561A (en) Topical formulations of 9-(2-hydroxyethoxymethyl)guanine
NZ197458A (en) O-alkoxyalkanoyl derivatives of adenine nucleosides
ZA833947B (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
AU7938482A (en) Novel derivatives of guanine
AU1708083A (en) Novel derivatives of guanine ii
SE8205959D0 (sv) Novel derivatives of guanine
IE812946L (en) Guanine derivatives
IT8221520A0 (it) Procedimento per la preparazione della 9-(2-idrossietossiemtil)guanina
GR871303B (en) 9-(2-hydroxy- ethoxy-methyl) guanine or acyclovir
LV5174A3 (lv) Panemiens "aciklovira" 9-(2-oksietoksimetil)guanina emulsijas iegusanai
SG114493G (en) Antiviral guanine derivatives